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HumanT cell leukemia viruses (HTLVs) are complex human retroviruses of the Deltaretro-
virus genus. Four types have been identiﬁed thus far, with HTLV-1 and HTLV-2 much more
prevalent than HTLV-3 or HTLV-4. HTLV-1 and HTLV-2 possess strictly related genomic
structures, but differ signiﬁcantly in pathogenicity, as HTLV-1 is the causative agent of adult
T cell leukemia and of HTLV-associated myelopathy/tropical spastic paraparesis, whereas
HTLV-2 is not associated with neoplasia. HTLVs code for a protein named Tax that is
responsible for enhancing viral expression and drives cell transformation. Much effort
has been invested to dissect the impact of Tax on signal transduction pathways and to
identify functional differences between the HTLVTax proteins that may explain the distinct
oncogenic potential of HTLV-1 and HTLV-2.This review summarizes our current knowledge
of Tax-1 andTax-2 with emphasis on their structure, role in activation of the NF-κB (nuclear
factor kappa-B) pathway, and interactions with host factors.
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INTRODUCTION
The Human T cell leukemia viruses (HTLVs) are complex retro-
viruses, belonging to the primate T-lymphotropic virus (PTLV)
family. HTLVs are classiﬁed as Deltaretroviruses, together with
bovine leukemia virus (BLV) and simian T-lymphotropic viruses
(STLVs). HTLV-1 was originally described in 1980 (Poiesz et al.,
1980) and was the ﬁrst oncogenic retrovirus discovered in humans
(reviewed by Gallo, 2011; Currer et al., 2012). HTLVs originated
in Africa around 30,000–40,000 years ago through cross-species
transmission of STLVs from monkeys to man. The virus evolved
to HTLV and spread to different geographic regions with human
migration (Van Dooren et al., 2001). STLVs with high homology
to HTLVs are still present in Africa (Hajj et al., 2012). HTLVs are
transmitted both vertically and horizontally (reviewed in Watan-
abe, 2011;Yasunaga andMatsuoka, 2011; Lairmore et al., 2012) but
cell-to-cell transmission is essential andoccurs throughdirect con-
tact through the formation of a virological synapse (Nejmeddine
et al., 2005; Asquith et al., 2007; Majorovits et al., 2008).
HTLV-1 has received much scientiﬁc attention due to its ability
to transform primary human T-lymphocytes in cell culture and
its association with a neoplasia and a neuropathology (Matsuoka
and Jeang, 2007). The most important HTLV-1-associated dis-
eases are the adult T cell leukemia (ATL), a very aggressive form
of leukemia, and the HTLV-associated myelopathy/tropical spas-
tic paraparesis (HAM/TSP), a neurological demyelinating disease
(Osame et al., 1986; Bangham and Osame, 2005; Yoshida, 2010;
Gessain and Mahieux, 2012; Yamagishi and Watanabe, 2012).
Three additional genotypes of HTLV, named HTLV-2, HTLV-3,
and HTLV-4, have been isolated and characterized, with HTLV-
2 the most common after HTLV-1 (Manns and Blattner, 1991;
Mahieux and Gessain, 2009). Although HTLVs share a simi-
lar genomic structure, HTLV-2 is much less pathogenic than
HTLV-1 since it does not cause neoplastic disorders and is spo-
radically associated with cases of subacute myelopathy (Feuer
and Green, 2005). Understanding the molecular basis of the
different pathogenicity of HTLV-1 and HTLV-2 may thus pro-
vide important clues to the molecular mechanisms of cancer.
All HTLVs possess an open reading frame (ORF) encoding the
Tax transactivator, which is essential for proviral gene expres-
sion from the viral long terminal repeat (LTR) promoter and
also regulates the expression and function of a number of cel-
lular genes and proteins (Feuer and Green, 2005; Wycuff and
Marriott, 2005; Calattini et al., 2006; Chevalier et al., 2006). Tax
alone is capable of modulating several pathways by activating
the transcription factors nuclear factor kappa-B (NF-κB) and
cyclic AMP responsive binding protein (CREB; Currer et al., 2012;
Tang et al., 2013a). Tax also interacts with proteins controlling
cell cycle checkpoints (Akagi et al., 1996; Chlichlia and Khazaie,
2010). HTLV-1 Tax (Tax-1) is necessary and sufﬁcient for T cell
immortalization (Akagi et al., 1995) and an ATL-like syndrome
has been observed in transgenic mice expressing Tax in the T
cell compartment (Ohsugi, 2013). It is noteworthy to mention
that in ATL patients, Tax expression is silenced in about 50%
of the patients. This observation, along with the fact that Tax
is capable of transforming primary T lymphocytes in vitro, sug-
gests that Tax might be important for establishing the leukemic
phenotype of ATL, but may become dispensable for its mainte-
nance. In addition, recent studies suggest that other viral gene
productsmay play relevant roles inHTLV-1-mediated transforma-
tion and may be responsible of the different HTLV-1 and HTLV-2
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pathogenicity, including the antisense HTLV-1 genome transcript
HBZ (Matsuoka and Jeang, 2011; Lairmore et al., 2012; Satou and
Matsuoka,2012; Zhao andMatsuoka,2012), theHTLV-1 accessory
protein p12 (Kannian and Green, 2010 ) and p13 (Silic-Benussi
et al., 2010a,b).
Tax-1 has been very extensively studied and its interactome
includes more than 100 proteins (for a recent review see Currer
et al., 2012). To further clarify this point and to better understand
the reasons for the difference in pathogenicity between HTLV-1
and HTLV-2 as well as from other HTLVs, in this review we have
focused on the structural and functional properties of the differ-
ent Tax proteins and their relations with other viral and cellular
factors. The following sections highlight recent advances in the
comprehension of: (i) the transformation potential of Tax-1, Tax-
2, Tax-3, and Tax-4 proteins; (ii) Tax’s role in the deregulation
of signal transduction focusing on studies which describe novel
interactions of Tax proteins with host factors and contribute to
the understanding of the molecular mechanisms of cell response
to viral infection; and (iii) Tax-mediated activation of the NF-
κB pathway focusing on differences between Tax-1 and Tax-2
involvement in canonical and non-canonical pathways.
SPECIFIC FEATURES OF DIFFERENT HTLV GENOTYPES
Following the discovery of HTLV-1 in 1980, three additional
HTLVs were found: HTLV-2 in 1982 (Kalyanaraman et al., 1982;
Vandamme, 2000; Gallo, 2002) and HTLV-3 and HTLV-4 in 2005
(Calattini et al., 2005; Wolfe et al., 2005). These four genotypes
show speciﬁc geographical areas of distribution. HTLV-1, which
includes seven subtypes (HTLV-1A to -1G), is endemic in Japan,
sub-Saharan Africa, South America, the Caribbean Islands, and
Melanesia. About 5–10million people worldwide are infectedwith
HTLV-1, most of whom are expected to remain asymptomatic
throughout their lifetime (Gessain andCassar,2012). An estimated
2–5% of infected people develop clinical complications including
ATL, HAM/TSP, infective dermatitis, uveitis, arthritis, and infec-
tion by Strongyloides stercoralis (Gonçalves et al., 2010). HTLV-2,
for which the four subtypes -2A to -2D are known, is endemic
within the Amerindian and Pygmy populations, and was found to
be epidemic in intravenous drug users (Feuer and Green, 2005).
In contrast to HTLV-1, HTLV-2 does not cause proliferative blood
diseases. However, HTLV-2 has been linked to neurological disor-
ders, arthritis, pneumonia, and with increased mortality (Araujo
and Hall, 2004; Roucoux and Murphy, 2004; Biswas et al., 2010).
The two new genotypes, termed HTLV-3 and HTLV-4, were dis-
covered in asymptomatic individuals from Cameroon (Calattini
et al., 2005; Wolfe et al., 2005); the pathogenic potential of these
viruses is still unknown. HTLV-3 is closely related to the simian
virus STLV-3, whereas an STLV corresponding to HTLV-4 has not
yet been found (Sintasath et al., 2009).
Comparative studies of the genomic sequences of all fourHTLV
genotypes have highlighted common as well as unique molecular
features. HTLV-1 and HTLV-2 have a similar genomic struc-
ture and share approximately 70% nucleotide sequence homology
(Feuer and Green, 2005). HTLV-3 and HTLV-4 have a genomic
organization which is similar to that of HTLV-1 and HTLV-2 with
the presence of gag, pro, pol, and env ORFs as well as of tax and
rex, whereas ORFs for auxiliary proteins still need to be conﬁrmed
FIGURE 1 | Schematic representation of HTLV-1, HTLV-2, HTLV-3, and
HTLV-4 genomic organization. Green colored boxes indicate ORF
encoding regulatory proteins. Dark orange colored boxes indicate ORF
encoding auxiliary proteins. Light orange colored boxes indicate putative
ORF deduced by genomic sequences analyses.
(Gessain et al., 2013; Figure 1). HTLV-3 shares about 62% identity
with HTLV-1 and HTLV-4 shares 62–71% nucleotide similarity
with HTLV-1, HTLV-2, and HTLV-3 (Switzer et al., 2006). HTLV-
3 and HTLV-4 present LTRs that lack the distal 21 bp transcription
regulatory repeat sequence (Switzer et al., 2006). BothHTLV-3 and
HTLV-4 present on the antisense strand a potential ORF named
APH-3 andAPH-4, respectively (antisense protein of HTLV), anal-
ogous to the HBZ gene of HTLV-1 (Larocque et al., 2011) and
APH-2 of HTLV-2 (Halin et al., 2009). Sequence alignment indi-
cated that APH-3 and APH-4 are more closely related to APH-2
than to HBZ (Larocque et al., 2011). The proteins also present
some differences, as APH-2, APH-3, and APH-4 do not contain
a consensus bZIP (basic leucine zipper) domain present in HBZ,
and differ in their subcellular localization as compared to HBZ
(Halin et al., 2009; Larocque et al., 2011).
COMPARISON OF Tax PROTEINS STRUCTURES
The tax gene is encoded within the pX region of HTLV, located
between env and the 3′-LTR, and is highly conserved among all
four genotypes and different subtypes of the virus (Currer et al.,
2012). The Tax protein is common to all primate members of
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the PTLV family. The primary amino acids (aa) sequence of Tax-
1 is composed of 353 residues, and is organized into functional
domains that have been extensively investigated (Bertazzoni et al.,
2011; Currer et al., 2012). The structural and functional domains
of Tax-1, Tax-2, Tax-3, and Tax-4 are shown in Figure 2. The
N-terminal region of Tax-1 contains a CREB-binding region (Yin
et al., 1995) that spans aa 1–60. This region is involved in the
interaction with ATF/CREB transcription factors and represents
a binding domain required for interaction with proteins involved
in transcription, cell cycle progression, and cell signaling regu-
lation (Suzuki et al., 1993a; Goren et al., 1995). All Tax proteins
contain the CREB-binding domain within their N-terminus. A
nuclear localization signal (NLS) is located within the ﬁrst 60 aa
in Tax-1 (Smith and Greene, 1992), Tax-3 and Tax-4 (Calattini
et al., 2006; Switzer et al., 2009). A nuclear localization determi-
nant (NLD) is present within the ﬁrst 42 aa in Tax-2 (Sheehy
et al., 2006; Turci et al., 2006a). An additional localization domain
is attributed to Tax-2 at aa position 90–100, which confers to
the protein a more abundant accumulation into the cytoplasm
as compared to Tax-1 (Meertens et al., 2004a). All four Tax pro-
teins contain a conserved region representing a nuclear export
sequence (NES) that has been functionally characterized in both
Tax-1 and Tax-2 and is located at aa position 189–202 in Tax-1
(Alefantis et al., 2003; Chevalier et al., 2005). Two leucine zipper-
like motif regions (LZRs) are present at aa 116–145 and 213–248
in Tax-1 and conserved in Tax-2, Tax-3, and Tax-4 as well. These
regions are required for protein dimerization and binding of cel-
lular factors (Jin and Jeang, 1997; Basbous et al., 2003). Tax-1
and Tax-3 are characterized by the presence of a PDZ-binding
motif (PBM) at the C-terminal region (Chevalier et al., 2006)
whereas this ismissing inTax-2 andTax-4. This domain is required
for interactions between Tax-1 and cellular factors such as the
tumor suppressors hDlg, MAGI-1, and Scribble and the synapse-
associated protein DlgI (Rousset et al., 1998; Suzuki et al., 1999;
Okajima et al., 2008; Yoshida et al., 2008; Makokha et al., 2013).
The absence of the PDZ domain renders Tax-2 unable to inter-
act with these factors. The four subtypes of HTLV-2 (-2A to
-2D) code for similar but not identical Tax proteins. Tax-2A is
composed of 331 aa and is shorter than Tax-2B, Tax-2C, and
Tax-2D (356, 356, and 344 aa, respectively; Feuer and Green,
2005), Tax-2B is the variant that has been studied in greatest
detail (Bertazzoni et al., 2011). Tax-1 and Tax-2B share 85% aa
similarity, whereas Tax-3 displays 26 and 30% divergence with
respect to Tax-1 and Tax-2, respectively. The comparison of Tax-4
FIGURE 2 | Structural and functional domains of theTax proteins.The position of the lysines and their ubiquitination, sumoylation, and acetylation are
indicated. Red dots identify phosphorylated serines.
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with Tax-1, Tax-2, and Tax-3 shows 83, 91, and 85% aa simi-
larity, respectively (Switzer et al., 2009), as outlined in Figure 3.
The main characteristic that distinguishes Tax-1 from Tax-2 is
the presence only in Tax-1 of a motif spanning aa 225–232
that activates the non-canonical NF-κB pathway through interac-
tion with the p100 factor (Shoji et al., 2009). A second relevant
difference between Tax-1 and Tax-2 is the presence in Tax-1,
but not in Tax-2, of the PBM at the C-terminus (Higuchi and
Fujii, 2009; Bertazzoni et al., 2011; Rende et al., 2012). Based
on sequence homology, all the Tax proteins possess two func-
tional regions involved in CBP (CREB-binding protein)/p300
binding: a KID-like domain between residues 81 and 95 and a
second domain named C-terminal transcriptional activating CR2
domain, between aa 312 and 319. These domains present some
differences between Tax-1, Tax-2, Tax-3, and Tax-4. One of the
major differences is related to the lysine residue at position 85,
which is necessary for Tax-1 to bind CBP/p300 (Hiramatsu and
Yoshikura, 1986); this residue is substituted by an arginine in
Tax-2, Tax-3, and Tax-4 (Calattini et al., 2006; Chevalier et al.,
2006).
Post-translational modiﬁcations of Tax-1 and Tax-2 such as
phosphorylation, acetylation, ubiquitination, and sumoylation
have been extensively described in recent reviews (Bertazzoni et al.,
2011; Lodewick et al., 2011; Kfoury et al., 2012). Recent compara-
tive analyses of Tax-1 and Tax-2 post-translational modiﬁcations
centered on the contribution of ubiquitination and sumoylation
to the intracellular localization of Tax and its ability to activate
NF-κB (Lamsoul et al., 2005; Kfoury et al., 2006; Nasr et al., 2006;
Turci et al., 2009, 2012; Bonnet et al., 2012; Xiao, 2012; Zane and
Jeang, 2012; Journo et al., 2013). These studies highlighted the
role of speciﬁc lysines as targets for sumoylation and ubiquitina-
tion in Tax-1 and Tax-2 (lysines K1 to K10 in Tax-1, see Figure 2).
Lysines K6 and K8 are critical for NF-κB activation and are highly
conserved in all Tax proteins. Additional lysines, indicated by addi-
tional roman numbers, are present in Tax-2 (K2i, K3i, K3ii, and
K10i, Figure 2) whereas Tax-3 and Tax-4 contain 11 and 10 lysines,
respectively, but not all are conserved at the same position. Align-
ment of the predicted Tax-4 sequence shows the absence of K10,
which is a target of acetylation in Tax-1 and possibly in Tax-2
(Lodewick et al., 2009; Journo et al., 2013).
FIGURE 3 | ClustalW alignments ofTax-1,Tax-2B,Tax-3, andTax-4 proteins.
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Tax is generally deﬁned as a multifunctional protein, since it
is able to activate both viral and host gene transcription and
to act as mediator of several cellular pathways. Of particular
importance was the demonstration that Tax-1 is able to immortal-
ize and transformhuman primary CD4+ T cells (Grassmann et al.,
1992; Franchini, 1995; Yoshida, 2001) and the ﬁnding that Tax-
1-transgenic mice develop ATL (Hasegawa et al., 2006; Ohsugi,
2013). It is well-established that Tax-1 plays a relevant role in the
oncogenesis induced byHTLV infection. Tax-1 acts as a pleiotropic
protein conferring proliferative and survival properties to HTLV-1
– infected cells by modulating regulatory factors that induce cell
proliferation, cell cycle progression, inhibition of apoptosis, and
interference with DNA repair. The main factors include CREB,
CBP/p300, NF-κB, cyclin-dependent kinases (CDKs), and Akt
(reviewed by Kannian and Green, 2010; Currer et al., 2012).
TRANSFORMATION POTENTIAL OF Tax PROTEINS
Tax-1 is able to transform T-lymphocytes and ﬁbroblasts and to
induce tumors in transgenic mice (Azran et al., 2004; Matsuoka
and Jeang, 2007; Kannian and Green, 2010; Ohsugi, 2013). The
ability to transform primary human T cells was also demonstrated
for Tax-2 (Ross et al., 1996; Feuer and Green, 2005). Both pro-
teins are able to inhibit the function of the tumor suppressor p53.
A comparative study between Tax-1 and Tax-2 subtypes demon-
strated that Tax-2A inhibits p53 function less efﬁciently than Tax-1
or Tax-2B (Mahieux et al., 2000). Although several in vitro studies
have investigated the ability of Tax to inactivate p53 (Tabakin-Fix
et al., 2006) by acting on the CREB or NF-κB pathway, the mech-
anism of this inhibition has not yet been completely clariﬁed. A
recent study by Zane et al. (2012) identiﬁed a cooperative role
for the cellular factor Wip1 (wild-type p53-induced phosphatase
1) in Tax-1-mediated inactivation of p53; a subsequent study
demonstrated interactions between Tax-1 and Wip1 (Dayaram
et al., 2013). In a study that employed transgenic mice express-
ing Tax-1 which develop mature T cell leukemia and lymphoma,
Ohsugi et al. (2013) demonstrated that Tax-1 alters p53 function
and that this effect precedes NF-κB activation.
Tax-2 transforms rat ﬁbroblasts less efﬁciently than Tax-1
(Endo et al., 2002). On the other hand, both viruses immortal-
izes primary human T cells at a comparable efﬁciency (Feuer
and Green, 2005). Higuchi et al. (2007) demonstrated that the
non-canonical NF-κB factor p100 and the PBM present in Tax-
1, but not in Tax-2, are essential for the transformation of a T
cell. Tsubata et al. (2005) had already shown that the PBM domain
is critical for the ability of Tax-1 to induce interleukin-2 (IL-2)-
independent growth of the IL-2-dependent T cell line CTLL-2,
and that Tax-2 lacks this ability. Xie et al. (2006) showed that the
deletion of the PBM in a recombinant HTLV-1 molecular clone
(HTLV-1/PBM) alters the requirement for the establishment and
maintenance of persistent infection in rabbits. A motif responsible
for the distinct transforming activity of Tax-1 and Tax-2 was iden-
tiﬁed by using a series of Tax-1/Tax-2 chimeric proteins. A region
corresponding to aa 225–232 of Tax-1 was shown to play a cru-
cial role in Tax-1’s transforming activity, involving stimulation of
the non-canonical NF-κB/p100 pathway (Shoji et al., 2009). Imai
et al. (2013) recently demonstrated that Tax-2B can immortalize
human CD4+ T cells. By infecting peripheral blood mononuclear
cells (PBMCs) with lentiviruses encoding Tax-1 or Tax-2B they
observed a higher immortalization activity of Tax-2B as compared
to Tax-1.
Studies of Tax-2-immortalized T cells demonstrated that Tax-2
causes a dysregulation of autophagy; this may represent a novel
survival mechanism in Tax-2-immortalized T cells (Ren et al.,
2012). A similar action was attributed to Tax-1, thus suggesting
that autophagy may play an important role in the HTLV life cycle
(Tang et al., 2013b). Tax-3 was shown to be able to activate the
NF-κB pathway and bind CBP in the T cell line CEM, thus sug-
gesting that Tax-3 has in vitro transforming activity (Chevalier
et al., 2006). The transforming properties of Tax-4 remain to be
investigated.
Tax AND SIGNAL TRANSDUCTION DEREGULATION
The role of Tax in HTLV-1-induced oncogenesis has been inves-
tigated in large part by analyzing the capacity of Tax-1 to interact
with selected cellular factors that play a crucial role in signaling
pathways. A list of Tax-interacting proteins is presented in Table 1.
Tax-1 expression deregulates several signaling pathways involved
in the cell cycle, cell proliferation, and cell survival, primarily
through the deregulation of two major cellular transcription fac-
tor pathways: CREB/ATF and NF-κB (Sun and Yamaoka, 2005;
Nyborg et al., 2010). Tax-1 constitutively activates NF-κB by
causing a deregulated expression of a variety of cellular genes.
Tax-dependent NF-κB activation has been extensively studied and
the current state of knowledge will be described in the next
section. Tax-1 activation through the cellular transcription fac-
tor CREB has been well-characterized at the level of the HTLV-1
promoter located in the LTR region. Within the HTLV-1 pro-
moter three conserved 21 bp repeat enhancer elements called
viral CRE elements (vCRE) are present that can be recognized
within a complex containing Tax-1 and a phosphorylated form
of CREB. The Tax/CREB/vCREB complexes can be associated
to other host factors. The best characterized are the cellular
coactivators CBP and p300 (Kashanchi and Brady, 2005), which
stimulate Tax-mediated transactivation by chromatin remodel-
ing (Nyborg et al., 2010). In addition, Tax-1 interacts with the
SWI/SNF chromatin remodeling complexes (Easley et al., 2010)
and may be involved in the nucleosome eviction activity medi-
ated by the nucleosome assembly protein 1 (NAP1; Sharma
and Nyborg, 2008). Additional host factors that directly inter-
act with Tax-1 and act in the Tax-mediated transactivation are
the transducer of regulated CREB (TORC) proteins. TORC-1
and TORC-2 are required for Tax activation whereas TORC-
3 enhances Tax-dependent transcription (Koga et al., 2004; Siu
et al., 2006). Several cellular factors that interact with Tax and
participate to HTLV-1 promoter activation have been identiﬁed.
The transcriptional activator CIITA affects the functional interac-
tion of the transcription factors CREB, ATF1, and PCAF with
Tax-1 (Tosi et al., 2011) and Tax-2 activation of HTLV-2 LTR
is strongly inhibited by CIITA (Orlandi et al., 2011). Recently,
Tang et al. (2013a) demonstrated that the LKB1 tumor suppres-
sor and the salt inducible kinases (SIKs) act as negative regulatory
factors in the activation of HTLV-1 LTR by Tax. They showed
that LKB1 and SIK interact with Tax and that this association
enables LTR activation by TORCs, CREB, and Tax-1 (Tang et al.,
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Table 1 |Tax-1 interacting proteins and deregulated pathways.
Pathways Factors Reference
G proteins Gβ subunit
Rho GTPases
Twizere et al. (2007)
Wu et al. (2004)
MAPKs MEKK1
TAK1
Yin et al. (1998)
Wu and Sun (2007)
JNK GPS2 Jin et al. (1997)




Mori et al. (2001)
NF-κB IKKα
IKKβ
Chu et al. (1998)
IKKγ/NEMO Harhaj and Sun (1999)
IkBα Suzuki et al. (1995)
IkBγ Hirai et al. (1994)
RelA Suzuki et al. (1994)
p100 Béraud et al. (1994)






Wu and Sun (2007)
Journo et al. (2013)
Journo et al. (2009)
Yasunaga et al. (2011)
Journo et al. (2009)
CREB CBP/p300 Kwok et al. (1996)
CREM Suzuki et al. (1993a)
ATF-4 Reddy et al. (1997)
XBP-1 Ku et al. (2008)
TORC Koga et al. (2004)
LKB1 Tang et al. (2013a)
Tang et al. (2013b)
Chan et al. (2013)




SW1/SNF PBAF Easley et al. (2010)
HDAC CBP/p300 Ego et al. (2002)
Histone modiﬁcation CARM1/SMYD3 Yamamoto et al. (2011)
SRF SRF Fujii et al. (1992)
Elk-1
SAP-1
Shuh and Derse (2000)
Microtubule formation TAB2 Yu et al. (2008)
hsMAD1/TXBP181 Jin et al. (1998)
Tax1BP2 Ching et al. (2006)
G1/S transition Cdk4
Cdk6
Haller et al. (2002)
(Continued)






Durkin et al. (2008)
Dayaram et al. (2013)
PI3K/Akt1 signaling Beclin1 Cheng et al. (2012)
PI3KC3
Tumor suppression MAGI-1 Makokha et al. (2013)
Scribble Okajima et al. (2008)
hDlg Suzuki et al. (1999)
2013a). Additional cellular mediators of Tax-induced activation
of HTLV-1 LTR belong to the group I p21-activated kinases
(Paks) which physically interact with Tax and CREB-regulating
transcriptional coactivators to facilitate HTLV-1 transcription
(Chan et al., 2013).
The role of Tax-1 in the expression of cellular genes containing
CRE elements was demonstrated for several genes involved in cell
cycle and proliferation. Recently Kim et al. (2010) demonstrated
that Tax-1 deregulates cyclin D1 gene expression thus determining
its overexpression. The mechanism requires an enhanced bind-
ing between p300 and phosphorylated CREB and TORC-2. The
interaction of Tax-1 with CREB/ATF factors also represses the
expression of several genes, including cyclin A (Kibler and Jeang,
2001), p53 (Mulloy et al., 1998), c-myc (Semmes et al., 1996a), and
the ZNF268 gene, which plays a role in the differentiation of blood
cells during development and in the pathogenesis of leukemia
(Wang et al., 2008).
The main functional and structural differences between Tax-1,
Tax-2, and Tax-3 are presented in Table 2. It is evident that the Tax
proteins differ not only in their transformation abilities, structural
properties, and protein interactions, as described in the previous
sections, but also in additional aspects of cellular interactions. Tax-
2 is distributed both in the nucleus and in the cytoplasm, showing
a more diffuse distribution in the cytoplasm compared to Tax-
1 (Turci et al., 2009). We have recently demonstrated that Tax-1
andTax-2 colocalizewith TAB2-containing cytoplasmic structures
that include RelA and calreticulin (Avesani et al., 2010). Com-
pared to Tax-1, Tax-2 differs in post-transcriptional modiﬁcation
(Lodewick et al., 2011) and we have shown that, in transfected
cells, lysine usage for sumoylation differs between Tax-1 and
Tax-2 (Turci et al., 2012). When compared to Tax-1, Tax-2 is
less efﬁcient in the induction of micronuclei formation (Semmes
et al., 1996b), is unable to suppress multilineage hematopoiesis
from CD34+ cells in vitro (Tripp et al., 2003) and to direct the
lipid raft translocation of IκB kinase alpha (IKKα) and IKKβ
in transfected cells and in Tax-2-immortalized primary T cells
(Huang et al., 2009).
Recent reports have investigated the different role of Tax-1
and Tax-2 in innate immunity. We have previously demon-
strated that HIV-1/HTLV-2 coinfection in drug users is asso-
ciated to a delayed progression of AIDS (Turci et al., 2006b).
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Table 2 | Summary of main functional and structural differences betweenTax-1,Tax-2, andTax-3.
Tax-1 Tax-2a Tax-3 Reference
Transactivating activity Higherb Lowerb n.d.c Semmes et al. (1996a)
Transformation capacity Higher Lower n.d. Endo et al. (2002)
Micronuclei formation + - n.d. Semmes et al. (1996b)
Cell cycle arrest + - n.d. Tripp et al. (2005)
Hematopoiesis suppression + - n.d. Tripp et al. (2003)
Reduction of histone gene expression + - n.d. Harrod et al. (2000); Ego et al. (2002)
Inhibition of p53 functions Higher Lower + Mahieux et al. (2000); Meertens et al. (2004b),
Jeong et al. (2005); Calattini et al. (2006)
Total viral mRNA expression Higher Lower n.d. Li and Green (2007)
Proinﬂammatory cytokine expression Higher Lower n.d. Banerjee et al. (2007)
Presence of PDZ motif + - n.d. Feuer and Green (2005)
Interaction with PDZ-binding proteins + - + Higuchi and Fujii (2009)
Interaction with p100 + - n.d. Shoji et al. (2009)
Preferential cellular localization Nucleus Cytoplasm n.d. Turci et al. (2009)
NF-κB transactivation + + + Chevalier et al. (2012)
NF-κB transactivation (lipid raft translocation of IKK) + - n.d. Huang et al. (2009)
In vitro CK2 phosphorylation + - n.d. Bidoia et al. (2010)
Oligo-sumoylation + - n.d. Turci et al. (2009)
Nuclear bodies Larger Smaller n.d. Turci et al. (2009)
Ubiquitination and sumoylation + + n.d. Turci et al. (2012); Zane et al. (2012)
Nuclear localization + + + Calattini et al. (2006)
T cell immortalization + + + Chevalier et al. (2006); Imai et al. (2013)
aThe properties of Tax-2 include those described for Tax-2A and/or Tax-2B reported in the literature.
bHigher and lower refers to a comparison betweenTax-1 andTax-2.
cn.d.: not determined.
CC-chemokines are produced spontaneously by T lymphocytes of
HIV-1/HTLV-2 coinfected subjects (Lewis et al., 2000). Recently,
it has been demonstrated that Tax-1 and Tax-2 induce the
expression of the CC-chemokines MIP1-α/CCL 3 MIP-1β/CCL4,
and RANTES/CCL5 and that downregulate CCR5 in mono-
cytes and PBMCs (Barrios et al., 2011; Balistrieri et al., 2013).
Furthermore, a signiﬁcant decrease of HIV-1 replication has
been reported in cultures of PMBCs infected by HIV-1 and
treated with Tax-1 or Tax-2 (Barrios et al., 2013). In this in
vitro cell system the effect of Tax-2 on HIV-1 replication is
higher than that of Tax-1 and the authors suggest that Tax-
2 may act as an immunomodulatory protein during HTLV-2
infection.
An emerging role in HTLV-1 pathogenesis is attributed to the
antisense protein HBZ which contains a bZIP motif, required
to form heterodimers with cellular transcription factors. HBZ
inhibits viral and cellular expression by interacting with CREB
and additional transcription factors and, in contrast to Tax-1, is
consistently expressed in ATL cells (Matsuoka and Green, 2009).
Compared to HTLV-1, HTLV-2 expresses an antisense protein
named APH-2, which is structurally different from HBZ, lacking
the classical bZIP domain. APH-2 is able to interact with CREB
and to repress the activation of HTLV-2 gene expression mediated
by Tax-2 (Halin et al., 2009). A recent study has shown that APH-
2 may interact with Tax-2 and when co-expressed with Tax-2,
impairs the ability of Tax-2 to activate AP-1 transcription (Mar-
ban et al., 2012). AP-1 pathway involves several factors, including
Jun, Fos, Maf, and ATF that act on cell proliferation, apoptosis,
and oncogenic transformation (Shaulian and Karin, 2001). The
distinct structural and functional diversities of HBZ and APH-2
and their interactionswithTax proteinsmay be relevant for the dif-
ferent pathogenicity of HTLV-1 and HTLV-2 and the mechanisms
need to be further investigated.
Tax AND THE NF-κB PATHWAY
Enhanced NF-κB activation is one of the principal consequences
of the expression of Tax in the infected cells. The NF-κB fam-
ily of inducible transcription factors regulate diverse biological
processes, including the growth and survival of both T cells and
non-lymphoid cells. Activation of NF-κB transcription factors
occurs through two tightly controlled signaling processes known
as the canonical and non-canonical NF-κB pathways. The princi-
pal activators and regulators of these two pathways are illustrated
in Figure 4. The canonical pathway is activated by different recep-
tor signals including inﬂammatory cytokines, genotoxic stress,
antigens, and toll like receptors (TLRs), whereas the activation
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FIGURE 4 |Tax-1 andTax-2 interactions with factors of NF-κB pathway. Red arrows indicate Tax-1 interaction and the green arrows indicate Tax-2
interactions. Dashed proteins indicate the absence of interaction with Tax-2.
of the non-canonical pathway involves signaling molecules that
are recognized only by a speciﬁc subset of tumor necrosis fac-
tor receptors (TNFRs), such as lymphotoxin-β, BAFF, RANKL,
and TWEAK (Sun, 2011). The NF-κB transcription factors fam-
ily includes ﬁve members: RelA/p65, c-Rel, RelB, p50, and p52.
The p50 and p52 proteins are expressed as precursor proteins
named p105 and p100, respectively. The processing of these pre-
cursors to mature forms requires proteasome activity. The ﬁve
members form dimers with one another and can bind to a vari-
ety of target DNA sequences called κB sites to modulate gene
expression. p50 and p52 can activate transcription by forming
heterodimers with RelA/p65, c-Rel, or RelB. In the cytoplasm, the
NF-κB complexes are inactive since they are bound to inhibitory
IκB proteins (IκBα, IκBβ, IκB, etc.). Activation of the path-
way requires IκB protein degradation and translocation of NF-κB
dimers to the nucleus. The common step of activation is mediated
by the IKK complex, which phosphorylates IκB and targets it to
proteosomal degradation. The IKK complex consists of two active
kinases, IKKα and IKKβ, and the regulatory scaffolding protein
NEMO (IKKγ). Tax directly interacts with these factors, leading
to a persistent activation of NF-κB-mediated transcription. Tax-1
stimulates the activation of both the canonical and non-canonical
NF-κB pathway thought the interaction with the IKK factors; the
Tax/IKKγ interaction is required for recruiting Tax to the IKK
catalytic subunits and for Tax-mediated IKK activation (Sun and
Yamaoka, 2005).
Other cellular proteins are important for Tax-mediated NF-κB
activation. Tax-1 interacts with NRP/optineurin and TAX1BP1
(Journo et al., 2009; Shembade et al., 2011), and with the
ubiquitin-speciﬁc peptidase USP20 (Yasunaga et al., 2011). A
recent study demonstrated that Tax-1 promotes Bcl-3 expression
and nuclear translocation of RelA/p65 (Gao et al., 2013). Kim et al.
(2008) provided evidence that Tax-1 induces Bcl-3 expression pri-
marily through activation of the NF-κB pathway. Another recent
study has demonstrated that Tax-1 transactivates CD69, a marker
of early activation of lymphocytes, through bothNF-κB andCREB
signaling pathways (Ishikawa et al., 2013).
Tax-1-mediated activation of the non-canonical NF-κB path-
way is important in virus-induced tumorigenesis. A region of
Tax-1 spanning aa 225–232 is essential for activation of the non-
canonical pathway. In contrast to Tax-1, Tax-2 is not able to
activate the non-canonical pathway and does not interact with
or induce processing of p100 into p52 (Higuchi et al., 2007; Shoji
et al., 2009). Furthermore, Tax-2 has been demonstrated to not
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be able to interact with TRAF6, a protein with E3 ligase activity
that, in the presence of Tax-1, positively regulates the activation of
NF-κB pathway (Journo et al., 2013).
Ubiquitination and sumoylation of Tax-1 and Tax-2 are
involved in NF-κB activation (Lamsoul et al., 2005; Kfoury et al.,
2006; Nasr et al., 2006; Turci et al., 2009, 2012; Journo et al.,
2013). Both Tax proteins co-immunoprecipitate and colocal-
ize with IKKγ/NEMO, TAB2, and RelA/p65 in transfected cells
(Meertens et al., 2004a; Sun and Yamaoka, 2005; Avesani et al.,
2010). Expression of Tax proteins induces IKKα and RelA/p65
nuclear translocation (Higuchi et al., 2007; Ho et al., 2012). An
overactivation of NF-κB by Tax induces cellular senescence (Zhi
et al., 2011). By knockdown experiments, Ho et al. (2012) demon-
strated that chronic activation of NF-κB by Tax-1 results in
rapid senescence (Tax-induced rapid senescence, Tax-IRS) that
is dependent on IKKα and p65/RelA activation. The Tax-IRS
phenomenon constitutes a host checkpoint response to the over-
activation of NF-κB that prevents cellular transformation (Zhi
et al., 2011; Ho et al., 2012) and represents an interesting mecha-
nismof host cell protection from the deregulating activities of viral
proteins.
CONCLUSION
HTLV-1 and HTLV-2 can efﬁciently transform T-lymphocytes,
but only HTLV-1 causes ATL. Although additional viral products
play important roles in the HTLV pathogenesis, Tax represents
a key factor in the early stage of T cell oncogenesis. In this
review we have dissected the structural and functional features
of the HTLV Tax proteins, focusing mainly on Tax-1 and Tax-2.
These two proteins share many common properties including the
capacity of transforming and immortalizing T cells, of transacti-
vating NF-κB pathway and being modiﬁed by both ubiquitination
and sumoylation. They signiﬁcantly differ for the presence of a
PDZ motif, which is missing in Tax-2, and for the activation
of non-canonical NF-κB which is attributed only to Tax-1. The
knowledge derived by studying Tax’s interactions with cellular
factors and their effects on the induction of altered responses
in cell pathway regulation conﬁrms the complexity of HTLV
oncogenesis. An interesting issue that needs to be explored in
the future is the frequent downregulation of the expression of
viral genes coded by the plus-strand (including Tax) in circulat-
ing leukemic cells from ATL patients. This phenomenon is likely
due to epigenetic silencing of the plus-strand promoter, e.g., by
methylation and/or expression of repressors of the Polycomb fam-
ily (Satou and Matsuoka, 2012, 2013; Yamagishi and Watanabe,
2012). A pivotal mechanism that involves a circuit controlled
signaling by miRNA has been recently demonstrated by Yamag-
ishi et al. (2012) showing that miR-31 loss, in ATL primary cells,
mediated by Polycomb-dependent epigenetic gene silencing, is
associated to the overexpression of the NF-κB inducing kinase
NIK and leads to constitutive activation of NF-κB oncogenic
signaling.
It is likely that further studies aimed at dissecting the functional
differences between the Tax proteins will reveal novel functions of
host factors that are involved in the signal pathways altered in ATL
and may become potential targets for effective therapies against
leukemia.
The studies of the differences between Tax-1, Tax-2, Tax-3,
and Tax-4 interacting cell factors and transactivating activities will
provide useful information to the understating of Tax-1 structural
transformation that may open a new approach on HTLV studies
based on Tax-1 peculiarities and interactions with addition viral
products, that are not present in HTLV-2, HTLV-3, and HTLV-4
Tax proteins.
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